Jelle Wesseling
- Cancer Research top 0.1%
- Oncology top 0.5%
- Molecular Biology top 2%
- Radiology, Nuclear Medicine and Imaging top 0.5%
- Pathology and Forensic Medicine top 0.5%
- Co-authors
- Emiel J. RutgersJohn HilkensSjoerd RodenhuisEsther H. LipsMarie-Jeanne T. F. D. Vrancken PeetersClaudette E. LooSabine C. LinnMarc J. van de Vijver
- Topics
- Breast Cancer Treatment Studies (146 papers)HER2/EGFR in Cancer Research (63 papers)Breast Lesions and Carcinomas (59 papers)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Jelle Wesseling
271 papers receiving 10.4k citations
Peers
Comparison fields: 5 of 148
- Cancer Research 5.0k
- Oncology 4.3k
- Molecular Biology 3.3k
- Radiology, Nuclear Medicine and Imaging 2.6k
- Pathology and Forensic Medicine 2.2k
Countries citing papers authored by Jelle Wesseling
This map shows the geographic impact of Jelle Wesseling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jelle Wesseling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jelle Wesseling more than expected).
Fields of papers citing papers by Jelle Wesseling
This network shows the impact of papers produced by Jelle Wesseling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jelle Wesseling. The network helps show where Jelle Wesseling may publish in the future.
Co-authorship network of co-authors of Jelle Wesseling
This figure shows the co-authorship network connecting the top 25 collaborators of Jelle Wesseling. A scholar is included among the top collaborators of Jelle Wesseling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jelle Wesseling. Jelle Wesseling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 0 | |
| 4 | 5 | |
| 5 | 23 | |
| 6 | 25 | |
| 7 | 8 | |
| 8 | 11 | |
| 9 | 2 | |
| 10 | 10 | |
| 11 | 44 | |
| 12 | 173 | |
| 13 | 16 | |
| 14 | 4 | |
| 15 | 14 | |
| 16 | 15 | |
| 17 | 43 | |
| 18 | 16 | |
| 19 | Non-invasive longitudinal imaging of tumor progression using an 111Indium labeled CXCR4 peptide antagonist | 7 |
| 20 | 60 |
About Jelle Wesseling
Jelle Wesseling is a scholar working on Cancer Research, Oncology and Pathology and Forensic Medicine, having authored 281 papers that have together received 10.7k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (146 papers), HER2/EGFR in Cancer Research (63 papers) and Breast Lesions and Carcinomas (59 papers). The work is most often cited by research in Cancer Research (5.0k citations), Oncology (4.3k citations) and Pathology and Forensic Medicine (2.2k citations). Jelle Wesseling has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Emiel J. Rutgers, John Hilkens, Sjoerd Rodenhuis, Esther H. Lips, Marie-Jeanne T. F. D. Vrancken Peeters, Claudette E. Loo, Sabine C. Linn, Marc J. van de Vijver, Marieke E. Straver and Kenneth G. A. Gilhuijs. Their work appears in journals such as Nature, Nature Communications and Nature Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.